201 related articles for article (PubMed ID: 38783288)
1. Exploring the mechanism of 6-Methoxydihydrosanguinarine in the treatment of lung adenocarcinoma based on network pharmacology, molecular docking and experimental investigation.
Liu X; Ren Y; Qin S; Yang Z
BMC Complement Med Ther; 2024 May; 24(1):202. PubMed ID: 38783288
[TBL] [Abstract][Full Text] [Related]
2. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
[TBL] [Abstract][Full Text] [Related]
3. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
[TBL] [Abstract][Full Text] [Related]
4. Exploring the Mechanism of Zilongjin in Treating Lung Adenocarcinoma Based on Network Pharmacology Combined with Experimental Verification.
Zhang K; Chen X
Crit Rev Immunol; 2024; 44(5):27-40. PubMed ID: 38618726
[TBL] [Abstract][Full Text] [Related]
5. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
6. Integrating network pharmacology, bioinformatics, and experimental validation to unveil the molecular targets and mechanisms of galangin for treating hepatocellular carcinoma.
Li X; Zhou M; Chen W; Sun J; Zhao Y; Wang G; Wang B; Pan Y; Zhang J; Xu J
BMC Complement Med Ther; 2024 May; 24(1):208. PubMed ID: 38816744
[TBL] [Abstract][Full Text] [Related]
7. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods.
Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J
Gene; 2024 Aug; 918():148474. PubMed ID: 38670393
[TBL] [Abstract][Full Text] [Related]
8. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology and Molecular Docking Analysis on Molecular Targets and Mechanisms of Fei Jin Sheng Formula in the Treatment of Lung Cancer.
Zhang YC; Gao WC; Chen WJ; Pang DX; Mo DY; Yang M
Curr Pharm Des; 2023; 29(14):1121-1134. PubMed ID: 37138492
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic prediction and validation of Brevilin A Therapeutic effects in Lung Cancer.
Wang R; Gao C; Yu M; Song J; Feng Z; Wang R; Pan H; Liu H; Li W; Fan X
BMC Complement Med Ther; 2024 Jun; 24(1):214. PubMed ID: 38840248
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
Zhao XY; Yang YY; Feng JL; Feng CL
J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
[TBL] [Abstract][Full Text] [Related]
13. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
[TBL] [Abstract][Full Text] [Related]
14. [Blaps rynchopetera affects proliferation, migration, and invasion of non-small cell lung cancer: a study based on network pharmacology and in vivo and in vitro experiments].
Li XY; Ma K; Yan JN; You FC; Ma L
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3576-3588. PubMed ID: 37474991
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
[TBL] [Abstract][Full Text] [Related]
16. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
[TBL] [Abstract][Full Text] [Related]
18. Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer.
Wu Z; Zhu Z; Fu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4165-4181. PubMed ID: 38032489
[TBL] [Abstract][Full Text] [Related]
19. Qingfei Jiedu decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification.
Pan J; Yang H; Zhu L; Lou Y; Jin B
Front Pharmacol; 2022; 13():897966. PubMed ID: 36091822
[No Abstract] [Full Text] [Related]
20. Network pharmacological study and in vitro studies validation-Molecular dynamics simulation of Cistanche deserticola in promoting periodontitis and bone remodeling.
Shan C; Wu Z; Xia Y; Ji X; Zhang W; Peng X; Zhao J
Int Immunopharmacol; 2024 Jun; 135():112299. PubMed ID: 38776853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
